Effects of a series of dihydroanthracene derivatives on drug efflux in multidrug resistant cancer cells

Sandrine Alibert, Christiane Santelli-Rouvier, Madeleine Castaing, Michel Berthelot, G. Spengler, J. Molnár, Jacques Barbe

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

A set of 9,10-dihydro-9,10-ethano and ethenoanthracene derivatives was tested with the aim to quantify the effect observed on drug efflux. Structure activity relationships and molecular modeling studies allowed to define topological display of pharmacophoric groups for these reversal agents.

Original languageEnglish
Pages (from-to)253-263
Number of pages11
JournalEuropean Journal of Medicinal Chemistry
Volume38
Issue number3
DOIs
Publication statusPublished - Mar 1 2003

Fingerprint

Molecular modeling
Structure-Activity Relationship
Display devices
Cells
Derivatives
Pharmaceutical Preparations
Neoplasms

Keywords

  • 9,10-Dihydro-9,10-ethano and ethenoanthracene derivatives
  • Cancer cells
  • Chemosensitizers
  • Drug efflux
  • Multidrug resistance
  • P-glycoprotein
  • Structure activity relationships

ASJC Scopus subject areas

  • Molecular Medicine
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science

Cite this

Effects of a series of dihydroanthracene derivatives on drug efflux in multidrug resistant cancer cells. / Alibert, Sandrine; Santelli-Rouvier, Christiane; Castaing, Madeleine; Berthelot, Michel; Spengler, G.; Molnár, J.; Barbe, Jacques.

In: European Journal of Medicinal Chemistry, Vol. 38, No. 3, 01.03.2003, p. 253-263.

Research output: Contribution to journalArticle

Alibert, Sandrine ; Santelli-Rouvier, Christiane ; Castaing, Madeleine ; Berthelot, Michel ; Spengler, G. ; Molnár, J. ; Barbe, Jacques. / Effects of a series of dihydroanthracene derivatives on drug efflux in multidrug resistant cancer cells. In: European Journal of Medicinal Chemistry. 2003 ; Vol. 38, No. 3. pp. 253-263.
@article{2f51c92074874c15948b3636aaf4f721,
title = "Effects of a series of dihydroanthracene derivatives on drug efflux in multidrug resistant cancer cells",
abstract = "A set of 9,10-dihydro-9,10-ethano and ethenoanthracene derivatives was tested with the aim to quantify the effect observed on drug efflux. Structure activity relationships and molecular modeling studies allowed to define topological display of pharmacophoric groups for these reversal agents.",
keywords = "9,10-Dihydro-9,10-ethano and ethenoanthracene derivatives, Cancer cells, Chemosensitizers, Drug efflux, Multidrug resistance, P-glycoprotein, Structure activity relationships",
author = "Sandrine Alibert and Christiane Santelli-Rouvier and Madeleine Castaing and Michel Berthelot and G. Spengler and J. Moln{\'a}r and Jacques Barbe",
year = "2003",
month = "3",
day = "1",
doi = "10.1016/S0223-5234(03)00018-7",
language = "English",
volume = "38",
pages = "253--263",
journal = "European Journal of Medicinal Chemistry",
issn = "0223-5234",
publisher = "Elsevier Masson SAS",
number = "3",

}

TY - JOUR

T1 - Effects of a series of dihydroanthracene derivatives on drug efflux in multidrug resistant cancer cells

AU - Alibert, Sandrine

AU - Santelli-Rouvier, Christiane

AU - Castaing, Madeleine

AU - Berthelot, Michel

AU - Spengler, G.

AU - Molnár, J.

AU - Barbe, Jacques

PY - 2003/3/1

Y1 - 2003/3/1

N2 - A set of 9,10-dihydro-9,10-ethano and ethenoanthracene derivatives was tested with the aim to quantify the effect observed on drug efflux. Structure activity relationships and molecular modeling studies allowed to define topological display of pharmacophoric groups for these reversal agents.

AB - A set of 9,10-dihydro-9,10-ethano and ethenoanthracene derivatives was tested with the aim to quantify the effect observed on drug efflux. Structure activity relationships and molecular modeling studies allowed to define topological display of pharmacophoric groups for these reversal agents.

KW - 9,10-Dihydro-9,10-ethano and ethenoanthracene derivatives

KW - Cancer cells

KW - Chemosensitizers

KW - Drug efflux

KW - Multidrug resistance

KW - P-glycoprotein

KW - Structure activity relationships

UR - http://www.scopus.com/inward/record.url?scp=0037343913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037343913&partnerID=8YFLogxK

U2 - 10.1016/S0223-5234(03)00018-7

DO - 10.1016/S0223-5234(03)00018-7

M3 - Article

C2 - 12667692

AN - SCOPUS:0037343913

VL - 38

SP - 253

EP - 263

JO - European Journal of Medicinal Chemistry

JF - European Journal of Medicinal Chemistry

SN - 0223-5234

IS - 3

ER -